A long overdue recognition: COPD as a distinct predictor of cardiovascular disease risk

Affiliations

¹ Respiratory Evaluation Sciences Program, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.
² Respiratory Evaluation Sciences Program, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada msafavi@mail.ubc.ca.

Free article

Editorial

Joseph Emil Amegadzie et al. Eur Respir J. 2023.

Free article

. 2023 Aug 31;62(2):2301167.

doi: 10.1183/13993003.01167-2023. Print 2023 Aug.

¹ Respiratory Evaluation Sciences Program, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.
² Respiratory Evaluation Sciences Program, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada msafavi@mail.ubc.ca.

No abstract available

Conflict of interest statement

Conflict of interest: The authors have no potential conflicts of interest to disclose.

Quantifying COPD as a risk factor for cardiac disease in a primary prevention cohort.
Maclagan LC, Croxford R, Chu A, Sin DD, Udell JA, Lee DS, Austin PC, Gershon AS. Maclagan LC, et al. Eur Respir J. 2023 Aug 31;62(2):2202364. doi: 10.1183/13993003.02364-2022. Print 2023 Aug. Eur Respir J. 2023. PMID: 37385658